UBE2S and hepatocellular carcinoma: Our results proved that compared with the negative control group, UBE2S-knockdown significantly increased the chemotherapy sensitivity of HCC cells to 5-FU and oxaliplatin, indicating that the upregulation of UBE2S enhances chemoresistance of HCC.